(a) As regards KRW 52,560,00 and KRW 44,560,00 among them, from April 5, 2016 to November 4, 2016.

A. On March 31, 2010, the Plaintiff entered into an non-dividend cancer insurance contract with the Defendant with the content of guaranteeing prime contract that: (a) cancer treatment insurance money of 40,000,000 won at the first time after the cancer security commencement date (only once after the first time); and (b) on the pertinent date after the first diagnosis and confirmation date after the cancer security commencement date; (c) on the pertinent date after the diagnosis and confirmation date of each year, the Plaintiff continued to pay KRW 4,00,000 for cancer treatment life funds of 5 years (five times); (d) on September 13, 2010; (e) on the basis of a non-distribution operation agreement with the Defendant, the insurance period of 0,000 won for more than 0,000 won per day after the first diagnosis and confirmation date; (e) on the pertinent date after the first diagnosis and confirmation date of the diagnosis; (e) on the maximum of 0,000 won for non-distribution surgery, 30,0050,000 type cancer surgery.

(hereinafter “instant insurance contract”). (b)

The terms and conditions of the instant insurance contract relating to the instant case are as follows.

Article 15 (Definition and Confirmation of "Cancerance", "Other Apanceram" and "Apanceam") (1) The term "Cancerance" in this Agreement means a disease specified in attached Table 4 [excluding other amranceram and Apanceams (excluding other amranceram and Apamramrams)] in the Korean Standard Disease Classification.

(5) The diagnosis and determination of cancer, other cancer and sampling cancer shall be made by a person with a professional doctor's license of an autopsy pathology or clinical pathology, and such diagnosis and determination shall be made.